My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Sat 28 Nov 2009 | 13:49 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For A.P. Pharma, Inc.
A.P. Pharma, Inc. (APPA.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
APPA
on other exchanges
As of 27 Nov 2009
0.94
USD
Price Change
+0.01
Percent Change
+1.08%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Barr, John
49
2007
Senior Vice President - Research & Development
Prentki, Ronald
51
2008
President, Chief Executive Officer, Director
Tang, Kevin
42
2009
Independent Director
Rosenblatt, Toby
70
1983
Director
Turnbull, Gregory
70
2009
Director
Zerbe, Robert
58
2002
Director
Whelan, John
47
2009
Chief Financial Officer, Vice President - Finance
Goddard, Paul
59
2000
Chairman of the Board
Find out more about APPA.O
Insider Trading